• Fentanyl
• Fentanyl Lawyer
• Fentanyl Facts
• Fentanyl Patch
• Fentanyl Transdermal System
• Fentanyl Side Effect
• Fentanyl Recall
• Fentanyl Renewed Warning
• Fentanyl Leak
• Fentanyl Drug
• Fentanyl Lollipop Information
• Fentanyl I.V.
• Fentanyl Citrate Medication
• Fentanyl Spray
• Fentanyl Mylan
• Fentanyl Oralet
• Fentanyl & Duragesic Patch
• Fentanyl Images
• Fentanyl Withdrawal
• Fentanyl Overdose
• Fentanyl Abuse
• Cancer and Fentanyl
• Fentanyl Addiction
• Fentanyl Death
• Fentanyl Attorneys

 

• Actavis
• Actavis Patch
• Actavis Recall
• Actavis Pharmaceutical Company
• Actavis Products
• Actavis Totowa

 

• Duragesic Patch
• Duragesic Patch Defect
• Duragesic Patch Recall
• Duragesic Patch Conversion
• Duragesic Patch Dose
• Duragesic Patch Side Effects
• Duragesic Patch Lawsuits
• Duragesic Patch Patients
• Pain from Duragesic Patches
• Duragesic Patches Withdrawal
• Duragesic Patch Placement
• Duragesic Patch Abuse
• Duragesic Patch Medication

Find a Lawyer in Your State

Need Help?

• Accutane®
• Cerebral Palsy
• Darvocet®
• Denture Cream
• Depuy ASR™ Hip Implant
• Fosamax® Femur Fracture
• MiniMed Insulin Pump
• Multaq®
• Nephrogenic Systemic Fibrosis
• Paxil® Birth Defects
• Propecia®
• Shoulder Pain Pump
• Topamax®
• Truck Accident Lawyer
• Wellbutrin®
• Yaz® Birth Control

Founded in 1956, Actavis is one of the nation’s largest pharmaceutical companies. With more than 10,000 employees operating in over 40 countries, the group is responsible for developing, manufacturing and selling generic pharmaceuticals.

Actavis: Fentanyl Patches

One of the products produced by Actavis that has gained a lot of public attention is the Fentanyl Transdermal System, generic for Duragesic. The transdermal system is a pain patch that slowly releases fentanyl (a narcotic with 80 times the strength of morphine) into a patient’s blood stream via the skin. The patch comes in four different doses:

• Fentanyl Transdermal System CII 25mcg/hr
• Fentanyl Transdermal System CII 50mcg/hr
• Fentanyl Transdermal System CII 75 mcg/hr
• Fentanyl Transdermal System CII 100 mcg/hr

Actavis Recalls Fentanyl Patches

In February 2008, Actavis Inc., the U.S. manufacturing and marketing division of Actavis Group recalled 14 lots of the Fentanyl transdermal system CII patches. The voluntary recall was issued as a precaution. Working in conjunction with the U.S. Food and Drug Administration (FDA), Actavis recalled the patches based on a possible manufacturing defect that could result in a fentanyl overdose.

The recalled Actavis lots included:

Injury Claims Against Actavis

Patients who were harmed by the defective patches, or another Actavis product will likely have a legal claim against the pharmaceutical group. As a drug maker and manufacturer, Actavis has a responsibility to consumers across the nation and can be held reliable if patients are injured from their drugs.

Patients who experience a fentanyl overdose will likely die from respiratory depression. In cases involving wrongful death, the surviving family members will most likely be entitled to seek and recover compensation for their losses including:

• Emotional trauma
• Lost economic and social support
• Funeral/burial expenses
• Outstanding medical bills

Contact Us For Help

If you or a loved one has been harmed by an Actavis-produced medication, fill out the contact form and one of our defective drug attorneys will be in contact with you shortly. We will schedule a free consultation in which we can asses your case and answer any questions you may have.